tradingkey.logo

Embecta Corp

EMBC
12.080USD
+0.160+1.34%
收盘 12/24, 13:00美东报价延迟15分钟
706.63M总市值
7.38市盈率 TTM

Embecta Corp

12.080
+0.160+1.34%

关于 Embecta Corp 公司

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp简介

公司代码EMBC
公司名称Embecta Corp
上市日期Mar 21, 2022
CEOKurdikar (Devdatt)
员工数量1850
证券类型Ordinary Share
年结日Mar 21
公司地址300 Kimball Drive
城市PARSIPPANY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07054
电话18624010000
网址https://www.embecta.com/
公司代码EMBC
上市日期Mar 21, 2022
CEOKurdikar (Devdatt)

Embecta Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
27.73K
+99.66%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
27.72K
+99.70%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
24.21K
+79.71%
Mr. Pravesh Khandelwal
Mr. Pravesh Khandelwal
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%
地区USD
名称
营收
占比
United States
160.20M
54.21%
International
135.30M
45.79%
业务
地区
业务USD
名称
营收
占比
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
其他
58.93%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
其他
58.93%
股东类型
持股股东
占比
Investment Advisor
48.94%
Investment Advisor/Hedge Fund
31.49%
Hedge Fund
10.58%
Research Firm
5.48%
Pension Fund
2.25%
Individual Investor
1.46%
Bank and Trust
0.54%
Family Office
0.40%
Sovereign Wealth Fund
0.19%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
771
58.75M
107.09%
-8.51K
2025Q3
810
58.76M
110.40%
-1.03M
2025Q2
820
59.48M
109.25%
+307.16K
2025Q1
855
59.15M
106.14%
-2.75M
2024Q4
884
57.08M
105.66%
+385.73K
2024Q3
903
56.12M
114.14%
-1.32M
2024Q2
966
57.37M
112.89%
+262.03K
2024Q1
996
57.10M
113.18%
-8.07M
2023Q4
1007
56.71M
107.91%
+769.57K
2023Q3
972
57.63M
107.02%
+1.71M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
8.03M
13.73%
-278.98K
-3.36%
Jun 30, 2025
The Vanguard Group, Inc.
5.40M
9.24%
-1.27M
-19.01%
Jun 30, 2025
American Century Investment Management, Inc.
5.20M
8.88%
+1.38M
+36.25%
Jun 30, 2025
River Road Asset Management, LLC
3.24M
5.54%
+12.35K
+0.38%
Jun 30, 2025
Deerfield Management Company, L.P.
2.75M
4.7%
+29.18K
+1.07%
Jun 30, 2025
State Street Investment Management (US)
2.40M
4.1%
+15.14K
+0.64%
Jun 30, 2025
Yacktman Asset Management LP
2.37M
4.06%
+16.07K
+0.68%
Jun 30, 2025
Jefferies LLC
1.34M
2.3%
+769.71K
+134.33%
Jun 30, 2025
William Blair Investment Management, LLC
1.99M
3.41%
+14.23K
+0.72%
Jun 30, 2025
Millennium Management LLC
1.82M
3.12%
+937.99K
+105.75%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ETC 6 Meridian Small Cap Equity ETF
1.09%
State Street SPDR S&P Health Care Equipment ETF
0.85%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.65%
Invesco S&P Spin-Off ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.49%
Invesco S&P SmallCap Health Care ETF
0.48%
Global X Aging Population ETF
0.31%
Royce Quant Small-Cap Quality Value ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.19%
查看更多
ETC 6 Meridian Small Cap Equity ETF
占比1.09%
State Street SPDR S&P Health Care Equipment ETF
占比0.85%
Lattice Hartford Multifactor Small Cap ETF
占比0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比0.65%
Invesco S&P Spin-Off ETF
占比0.63%
Invesco NASDAQ Future Gen 200 ETF
占比0.49%
Invesco S&P SmallCap Health Care ETF
占比0.48%
Global X Aging Population ETF
占比0.31%
Royce Quant Small-Cap Quality Value ETF
占比0.29%
Inspire Small/Mid Cap ESG ETF
占比0.19%

分红派息

近5年累计派现 112.50M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Aug 08, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
May 09, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2025 going ex on May 28, 2025
May 28, 2025
Jun 13, 2025
May 28, 2025
Feb 06, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 14, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 14, 2025
Feb 28, 2025
Nov 26, 2024
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 18, 2024 going ex on Dec 06, 2024
Dec 06, 2024
Dec 18, 2024
Dec 06, 2024
Aug 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 13, 2024
Aug 27, 2024
May 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 14, 2024 going ex on May 24, 2024
May 28, 2024
Jun 14, 2024
May 24, 2024
Feb 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 15, 2024 going ex on Feb 27, 2024
Feb 28, 2024
Mar 15, 2024
Feb 27, 2024
Nov 21, 2023
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 15, 2023 going ex on Dec 01, 2023
Dec 04, 2023
Dec 15, 2023
Dec 01, 2023
Aug 08, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Sep 13, 2023
Aug 24, 2023
May 12, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2023 going ex on May 25, 2023
May 29, 2023
Jun 13, 2023
May 25, 2023
查看更多

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Embecta Corp的前五大股东是谁?

Embecta Corp 的前五大股东如下:
BlackRock Institutional Trust Company, N.A.持有股份:8.03M,占总股份比例:13.73%。
The Vanguard Group, Inc.持有股份:5.40M,占总股份比例:9.24%。
American Century Investment Management, Inc.持有股份:5.20M,占总股份比例:8.88%。
River Road Asset Management, LLC持有股份:3.24M,占总股份比例:5.54%。
Deerfield Management Company, L.P.持有股份:2.75M,占总股份比例:4.70%。

Embecta Corp的前三大股东类型是什么?

Embecta Corp 的前三大股东类型分别是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
American Century Investment Management, Inc.

有多少机构持有Embecta Corp(EMBC)的股份?

截至2025Q4,共有771家机构持有Embecta Corp的股份,合计持有的股份价值约为58.75M,占公司总股份的107.09%。与2025Q3相比,机构持股有所增加,增幅为-3.30%。

哪个业务部门对Embecta Corp的收入贡献最大?

在FY2025Q3,Pen Needles业务部门对Embecta Corp的收入贡献最大,创收216.90M,占总收入的73.40%。
KeyAI